What is Cosmo Pharmaceuticals N.V?
focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with a faster and less risky excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Relafalk, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers' diarrhoea; and Byfavo, an intravenous benzodiazepine sedative/anesthetic. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.57B, and a P/E ratio of 35.9x.
A short list of Drug Manufacturers - General names that are close enough in size to make side-by-side comparison useful.